Total Pulmonary Vein Occlusion as a Consequence of Catheter Ablation for Atrial Fibrillation Mimicking Primary Lung Disease
SABINE ERNST,FEIFAN OUYANG,MASAHIKO GOYA,FELIX LÖBER,CARSTEN SCHNEIDER,MARTIN HOFFMANN‐RIEM,STEFAN SCHWARZ,KLAUS HORNIG,KLAUS‐MICHAEL MÜLLER,MATTHIAS ANTZ,ECKHARD KAUKEL,CHRISTIAN KUGLER,KARL‐HEINZ KUCK
DOI: https://doi.org/10.1046/j.1540-8167.2003.02334.x
IF: 2.7
2003-04-01
Journal of Cardiovascular Electrophysiology
Abstract:INTRODUCTION: Catheter ablation has recently been used for curative treatment of atrial fibrillation.METHODS AND RESULTS: Three of 239 patients who underwent ablation close to the pulmonary vein (PV) ostia at our institute developed severe hemoptysis, dyspnea, and pneumonia as early as 1 week and as late as 6 months after the ablation. Because the patients were arrhythmia-free, the treating physician initially attributed the symptoms to new-onset pulmonary disease (e.g., bronchopulmonary neoplasm). After absent PV flow was confirmed by transesophageal echocardiography, transseptal contrast injection depicted a totally occluded PV in all three patients. Successful recanalization, even in chronically occluded Pvs, was performed in all patients. During follow-up, Doppler flow measurements by transesophageal echocardiography demonstrated restenosis in all primarily dilated PV, which led to stent implantation.CONCLUSION: PV stenosis/occlusion after catheter ablation of atrial fibrillation occurs in a subset of patients. However, because in-stent restenosis occurred in two patients after 6 to 10 weeks, final interventional strategy for PV stenosis or occlusion remains unclear. To prevent future PV stenosis or occlusion, a decrease in target temperature and energy of radiofrequency current or the use of new energy sources (ultrasound, cryothermia, microwave) seems necessary.
cardiac & cardiovascular systems